Literature DB >> 2872233

Interleukin 1 stimulates platelet-activating factor production in cultured human endothelial cells.

F Bussolino, F Breviario, C Tetta, M Aglietta, A Mantovani, E Dejana.   

Abstract

Monocyte-derived interleukin 1 (IL-1) was found to be a potent inducer of platelet-activating factor (PAF) in cultured human vascular endothelial cells (HEC). The product was identified as PAF by its behavior in chromatographic systems, its recovery of biological activity, and its physico-chemical properties and susceptibility to lipases. The response of HEC to IL-1 was concentration-dependent, took more than 2 h to become apparent, and decreased after 18 h of incubation. Most of the PAF produced was cell-associated and only a small amount (about 25% of the total) was released in the culture medium. To study the mechanism of IL-1-induced HEC-PAF production we tested the activity of 1-O-alkyl-sn-glycero-3-phosphocholine:acetyl/coenzyme A acetyltransferase in HEC. Acetyltransferase activity measured in IL-1-stimulated HEC lysates showed a three to five times greater maximum velocity, but the same Michaelis constant, as untreated cells. The regulation of PAF generation in HEC by IL-1 may be an important aspect of the two-way interaction between immunocompetent cells and vascular tissue.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2872233      PMCID: PMC370564          DOI: 10.1172/JCI112532

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  48 in total

1.  A rapid method of total lipid extraction and purification.

Authors:  E G BLIGH; W J DYER
Journal:  Can J Biochem Physiol       Date:  1959-08

2.  Activated macrophages induce vascular proliferation.

Authors:  P J Polverini; P S Cotran; M A Gimbrone; E R Unanue
Journal:  Nature       Date:  1977-10-27       Impact factor: 49.962

3.  Intravascular aggregation and pulmonary sequestration of platelets during IgE-induced systemic anaphylaxis in the rabbit: abrogation of lethal anaphylactic shock by platelet depletion.

Authors:  R N Pinckard; M Halonen; J D Palmer; C Butler; J O Shaw; P M Henson
Journal:  J Immunol       Date:  1977-12       Impact factor: 5.422

4.  Stimulation of nonlymphoid mesenchymal cell proliferation by a macrophage-derived growth factor.

Authors:  B M Martin; M A Gimbrone; E R Unanue; R S Cotran
Journal:  J Immunol       Date:  1981-04       Impact factor: 5.422

5.  Physicochemical and functional identity of rabbit platelet-activating factor (PAF) released in vivo during IgE anaphylaxis with PAF released in vitro from IgE sensitized basophils.

Authors:  R N Pinckard; R S Farr; D J Hanahan
Journal:  J Immunol       Date:  1979-10       Impact factor: 5.422

6.  Platelet-activating factor. Evidence for 1-O-alkyl-2-acetyl-sn-glyceryl-3-phosphorylcholine as the active component (a new class of lipid chemical mediators).

Authors:  C A Demopoulos; R N Pinckard; D J Hanahan
Journal:  J Biol Chem       Date:  1979-10-10       Impact factor: 5.157

7.  Enzymatic synthesis of 1-alkyl-2-acetyl-sn-glycero-3-phosphocholine, a hypotensive and platelet-aggregating lipid.

Authors:  R L Wykle; B Malone; F Snyder
Journal:  J Biol Chem       Date:  1980-11-10       Impact factor: 5.157

8.  Human platelet stimulation by acetyl glyceryl ether phosphorylcholine.

Authors:  L M McManus; D J Hanahan; R N Pinckard
Journal:  J Clin Invest       Date:  1981-03       Impact factor: 14.808

9.  Activation of human neutrophils with 1-O-hexadecyl/octadecyl-2-acetyl-sn-glycerol-3-phosphorylcholine (platelet activating factor).

Authors:  J O Shaw; R N Pinckard; K S Ferrigni; L M McManus; D J Hanahan
Journal:  J Immunol       Date:  1981-09       Impact factor: 5.422

10.  Leukocyte-dependent histamine release from rabbit platelets. The role of IgE, basophils, and a platelet-activating factor.

Authors:  J Benveniste; P M Henson; C G Cochrane
Journal:  J Exp Med       Date:  1972-12-01       Impact factor: 14.307

View more
  42 in total

1.  Effect of a selective PAF antagonist SM-10661 ((+/-)-cis-3,5-dimethyl-2-(3-pyridyl)thiazolidin-4-one HCl) on experimental disseminated intravascular coagulation (DIC).

Authors:  N Imanishi; Y Komuro; S Morooka
Journal:  Lipids       Date:  1991-12       Impact factor: 1.880

2.  Inducible release of an endothelial cell-specific protein.

Authors:  C W Carson; G G Hunder; K L Kaplan; C M Johnson
Journal:  Am J Pathol       Date:  1991-07       Impact factor: 4.307

Review 3.  Smoking, the oral contraceptive pill, and Crohn's disease.

Authors:  A J Wakefield; A M Sawyerr; M Hudson; A P Dhillon; R E Pounder
Journal:  Dig Dis Sci       Date:  1991-08       Impact factor: 3.199

Review 4.  Neo-intimal hyperplasia in vascular grafts and its implications for autologous arterial grafting.

Authors:  C Purcell; M Tennant; J McGeachie
Journal:  Ann R Coll Surg Engl       Date:  1997-05       Impact factor: 1.891

5.  Interleukin 1 inhibits contraction of vascular smooth muscle.

Authors:  D Beasley; R A Cohen; N G Levinsky
Journal:  J Clin Invest       Date:  1989-01       Impact factor: 14.808

6.  The effect of adrenalectomy on interleukin-1 release in vitro and in vivo.

Authors:  M Perretti; C Becherucci; G Scapigliati; L Parente
Journal:  Br J Pharmacol       Date:  1989-12       Impact factor: 8.739

Review 7.  The role of CD14 and lipopolysaccharide-binding protein (LBP) in the activation of different cell types by endotoxin.

Authors:  R R Schumann; E T Rietschel; H Loppnow
Journal:  Med Microbiol Immunol       Date:  1994-12       Impact factor: 3.402

8.  Involvement of leukotriene B4 and platelet-activating factor in cytokine priming of human polymorphonuclear leucocytes.

Authors:  A G Stewart; T Harris; M De Nichilo; A F Lopez
Journal:  Immunology       Date:  1991-02       Impact factor: 7.397

Review 9.  Leukotriene B4 and platelet-activating factor in human skin.

Authors:  L Michel; L Dubertret
Journal:  Arch Dermatol Res       Date:  1992       Impact factor: 3.017

10.  Preventive effects of interleukin 1 beta for ACNU-induced myelosuppression in malignant brain tumors: the experimental and preliminary clinical studies.

Authors:  S Tanaka; S Tabuchi; K Watanabe; H Takigawa; K Akatsuka; H Numata; Y Hokama; T Hori
Journal:  J Neurooncol       Date:  1992-10       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.